←
ACROBiosystems1,111 posts
ACROBiosystems avatar

ACROBiosystems

@ACROBio

An internationally recognized manufacturer of recombinant proteins and reagents to support the development of target therapeutics, vaccines, and diagnostics.

◷ Joined January 2016▧ 910 Photos and videos
ACROBiosystems avatar
ACROBiosystems@ACROBio·Sep 1

🧪 Back to the Lab? We've got your desk covered! Get organized with ACRO's desk essentials kit: a charging cable, mouse pad & magnetic wallet. There's still one month to join! Place an order for eligible ACRO products to claim your exclusive gifts. T&Cs apply.

Post attachment
ACROBiosystems avatar
ACROBiosystems@ACROBio·Aug 27

Register Now: event.on24.com/wcc/r/5464661… 🔬 Featured Talks Talk 1: Targeted-LNP Technology for Precision Genetic Medicine — Joe Yu, PhD Talk 2: From Delivery Vehicle to Cells: Enabling In Vivo CAR Development with Integrated End-to-End Solutions — Hui Yu, PhD

ACROBiosystems avatar
ACROBiosystems@ACROBio·Aug 27

🚀 Live Webinar: Exploring New Frontiers in In Vivo CAR-T Therapy Join us for an expert webinar exploring how targeted LNPs and integrated development solutions can accelerate the next generation of in vivo CAR-T therapies. 📅 Sept 15, 2026 🕙 10 AM PT | 1 PM ET | 5 PM GMT

Post attachment
ACROBiosystems avatar
ACROBiosystems@ACROBio·Aug 4

🔬 Back to the Lab. Gear up for a new research season with ACROBiosystems and earn the exclusive Desk Essentials Kit—featuring a magnetic wallet, charging cable, and mouse pad—to support your work, from your desk to the bench. 🔗 Claim your reward now: acrobiosystems.com/activitie…

Post attachment
ACROBiosystems avatar
ACROBiosystems@ACROBio·Jul 24

⏰️Only one week left to take home a limited-edition horseshoe crab pouch along with an AcroGreen badge — a small token celebrating ocean conservation and scientific exploration. 👉 Click here to participate in our Ocean-Inspired Discovery Campaign: acrobiosystems.com/activitie…

Post attachment
ACROBiosystems avatar
ACROBiosystems@ACROBio·Jul 21

Key Highlights: - Target biology in prostate cancer drug development - The impact of tumor heterogeneity on target selection - Modality selection for ADCs and TCEs - Emerging targets: PSMA, B7-H3, STEAP1, KLK2 & DLL3